1 April 2019
| Bethany E Higgins, Deanna J Taylor, David P Crabb (Prof)
|
EYE - Vitreo-Retinal
Age-related macular degeneration (AMD) is the primary cause of blindness in the developed world and is accountable for more than one half of sight impairment registrations within England and Wales [1]. AMD is prevalent in people aged 60 years and...
New evidence from an evaluation carried out by Helpforce for Friends of Moorfields shows that a volunteer’s support can help patients while they have eye surgery under local anaesthetic. 94% say the support helped them feel less anxious.
The authors describe an online tool which has the purpose of converting count finger measurements of visual acuity into Snellen equivalents. The purpose of this is to allow the re-interpretation of retrospectively collected data that provide visual acuity in this...
This series explores the four pillars of advanced clinical practice and here, Jem Ann Bautista explores the pillar of clinical practice. As day case theatre practitioners in one of London’s biggest and busiest centres, our team is trained to cater...
Fares Antaki. Nima Ghadiri (NG): The ‘retinal age gap’ (RAG) is a relatively new concept. Based on your study [1], how confident are you in proposing this as a non-invasive, accessible biomarker for accelerated biological ageing in patients with neuropsychiatric...
Cytotoxic T lymphocyte antigen-4 (CTLA4) binds both CD80 and Cd86 and inhibits T lymphocyte activation via CD28. Il-6 is a pleiotropic cytokine that has been associated with many autoimmune conditions including uveitis. Blockade of these molecules by either CTLA4-Ig, a...
Twenty-two young and healthy participants were recruited in this study. The authors showed that pupil size increased as a result of caffeine consumption. A more stable (lower variability of accommodation) accommodative response (AR) was induced by caffeine intake, whereas the...
This prospective European study looks at the response to tocilizumab in corticosteroid-resistant disease. Tocilizumab (TCZ) is a monoclonal antibody that competitively inhibits IL-6 binding to its receptor. Unlike teprotumumab, the advantage of TCZ is that it is already used within...
For Eye News Feb/Mar 2024, I was delighted to hear from Dr Hosam Aglan. In New Zealand at the time, Dr Aglan shared wonderful insights into the art of folding origami, along with images from his own creations. The role...
A male child is born at 31 weeks and requires 100% oxygen supplementation with intensive care. What would be the ophthalmic management of this child? In the first instance, it will be useful to know the screening criteria and protocol....
5 June 2023
| Fatima Kyari, Oteri Okolo, Elizabeth Awoyesuku, Adedeji Akinyemi, Covadonga Bascaran, Marcia Zondervan
|
EYE - General
This is the second in a series (see Part 1 here) of three articles about strengthening eye health services in Nigeria through collaboration with the LINKS and Networks run at the International Centre for Eye Health, LSHTM. This article highlights...